Stay updated on Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial page
- Check5 days agoChange DetectedThe page now displays Revision: v3.5.4 where it previously showed Revision: v3.5.3. This indicates a new build of the site behind the scenes rather than changes to the study content.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page’s footer “Revision” version has been incremented from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check33 days agoChange Detected- Revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check62 days agoChange DetectedNew page revision tag v3.5.0 was added. The previous revision tag v3.4.3 was removed.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This is a background version-label change that does not affect study details or user workflows.SummaryDifference0.1%

- Check98 days agoChange DetectedA new site revision label `Revision: v3.4.2` has been added. The previously displayed government funding status notice (lapse in funding) has been removed.SummaryDifference0.4%

Stay in the know with updates to Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial page.